[8-K] Capricor Therapeutics Inc Reports Material Event
Capricor Therapeutics furnished a press release announcing its financial results for the quarter ended June 30, 2025; the press release is attached as Exhibit 99.1. The company states the release is being furnished, not filed, and therefore is not subject to Section 18 liability and will not be incorporated by reference into other Exchange Act filings unless expressly stated. The filing also includes a Cover Page Interactive Data File (inline XBRL) as Exhibit 104. The report identifies Capricor common stock trading as CAPR on The Nasdaq Capital Market and is signed by CEO Linda Marbán, Ph.D.. Investors should review Exhibit 99.1 for the detailed financial figures because the 8-K text here provides only the notice of the release.
Capricor Therapeutics ha diffuso un comunicato stampa che annuncia i risultati finanziari per il trimestre chiuso il 30 giugno 2025; il comunicato è allegato come Exhibit 99.1. La società precisa che il comunicato è reso disponibile, non depositato, e pertanto non è soggetto alla responsabilità prevista dalla Section 18 e non sarà incorporato per riferimento in altri documenti ai sensi dell'Exchange Act, salvo espressa indicazione. La comunicazione comprende inoltre un Cover Page Interactive Data File (inline XBRL) come Exhibit 104. Il rapporto indica che le azioni ordinarie di Capricor vengono negoziate con il simbolo CAPR sul The Nasdaq Capital Market ed è firmato dalla CEO Linda Marbán, Ph.D.. Gli investitori devono consultare l'Exhibit 99.1 per i dati finanziari dettagliati, poiché il testo dell'8-K qui fornisce solo l'avviso del comunicato.
Capricor Therapeutics remitió un comunicado de prensa que anuncia sus resultados financieros del trimestre cerrado el 30 de junio de 2025; el comunicado se adjunta como Exhibit 99.1. La compañía declara que el comunicado se proporciona, no se presenta, por lo que no está sujeto a la responsabilidad prevista en la Section 18 y no se incorporará por referencia en otras presentaciones en virtud del Exchange Act salvo indicación expresa. La presentación incluye asimismo un Cover Page Interactive Data File (inline XBRL) como Exhibit 104. El informe indica que las acciones ordinarias de Capricor cotizan con el símbolo CAPR en The Nasdaq Capital Market y está firmado por la directora ejecutiva Linda Marbán, Ph.D.. Los inversores deben revisar el Exhibit 99.1 para conocer las cifras financieras detalladas, ya que el texto del 8-K aquí solo notifica el comunicado.
Capricor Therapeutics는 분기 종료일인 2025년 6월 30일자 분기 실적을 발표하는 보도자료를 제공했으며, 해당 보도자료는 Exhibit 99.1로 첨부되어 있습니다. 회사는 이 보도자료가 제출된 것이 아니라 제공된 것(furnished, not filed)이라고 밝히며, 따라서 Section 18에 따른 책임 대상이 아니고 명시적으로 언급되지 않는 한 다른 Exchange Act 제출서류에 참조로 편입되지 않는다고 명시했습니다. 이 제출서류에는 또한 Cover Page Interactive Data File (inline XBRL)이 Exhibit 104로 포함되어 있습니다. 보고서는 Capricor 보통주가 The Nasdaq Capital Market에서 CAPR로 거래되고 있음을 식별하며, CEO Linda Marbán, Ph.D.가 서명했습니다. 투자자는 상세 재무 수치는 Exhibit 99.1을 확인해야 하며, 이 8-K 본문에는 해당 보도자료의 공시 사실만 포함되어 있음을 유의하시기 바랍니다.
Capricor Therapeutics a publié un communiqué de presse annonçant ses résultats financiers pour le trimestre clos le 30 juin 2025 ; le communiqué est joint en tant que Exhibit 99.1. La société précise que le communiqué est fourni, non déposé (furnished, not filed) et n'est donc pas soumis à la responsabilité au titre de la Section 18 et ne sera pas incorporé par renvoi dans d'autres déclarations au titre de l'Exchange Act, sauf indication expresse. Le dépôt comprend également un Cover Page Interactive Data File (inline XBRL) en tant qu'Exhibit 104. Le rapport indique que les actions ordinaires de Capricor sont négociées sous le sigle CAPR sur The Nasdaq Capital Market et est signé par la PDG Linda Marbán, Ph.D.. Les investisseurs doivent consulter l'Exhibit 99.1 pour les chiffres financiers détaillés, car le texte du 8-K se limite ici à annoncer le communiqué.
Capricor Therapeutics hat eine Pressemitteilung veröffentlicht, die die Finanzergebnisse für das zum 30. Juni 2025 endende Quartal bekannt gibt; die Pressemitteilung ist als Exhibit 99.1 beigefügt. Das Unternehmen erklärt, die Mitteilung werde übermittelt, nicht eingereicht (furnished, not filed) und sei daher nicht der Haftung nach Section 18 unterworfen und werde nicht durch Verweis in andere Einreichungen nach dem Exchange Act aufgenommen, sofern nicht ausdrücklich angegeben. Die Einreichung enthält außerdem eine Cover Page Interactive Data File (inline XBRL) als Exhibit 104. Der Bericht weist darauf hin, dass die Capricor-Stammaktien unter dem Kürzel CAPR an der Nasdaq Capital Market gehandelt werden und ist von der Geschäftsführerin Linda Marbán, Ph.D. unterzeichnet. Anleger sollten Exhibit 99.1 zur Einsicht der detaillierten Finanzzahlen heranziehen, da der Text des 8-K hier nur die Veröffentlichung ankündigt.
- Press release furnished as Exhibit 99.1 announcing financial results for the quarter ended June 30, 2025.
- Cover Page Interactive Data File (inline XBRL) provided as Exhibit 104, enabling structured disclosure of cover-page data.
- No substantive financial figures or metrics are included in the 8-K text itself; investors must consult Exhibit 99.1 for the detailed results.
- The disclosure is furnished, not filed, which means it is not subject to Section 18 liability and will not be automatically incorporated by reference into other filings.
Insights
TL;DR Routine furnishing of Q2 results; limited immediate market impact without the press release text.
The 8-K notifies investors that Capricor has released its quarter-end financial results via a press release attached as Exhibit 99.1 and supplied inline XBRL as Exhibit 104. As the company expressly states the material is being furnished rather than filed, the disclosure does not carry Section 18 liabilities and is not automatically incorporated into other Exchange Act filings. On its face this is a procedural disclosure; the market impact depends on the actual figures and commentary contained in Exhibit 99.1.
TL;DR Procedural 8-K: disclosure furnished and signed by the CEO; no new governance actions reported.
The filing documents that management provided a press release reporting quarterly financial results and included a signed cover page. There are no governance changes, officer departures, equity awards, or other corporate actions disclosed in the text of this report. The explicit statement that the release is furnished (not filed) limits the filing's role in creating additional SEC liabilities and in being incorporated by reference in later filings absent express language to the contrary.
Capricor Therapeutics ha diffuso un comunicato stampa che annuncia i risultati finanziari per il trimestre chiuso il 30 giugno 2025; il comunicato è allegato come Exhibit 99.1. La società precisa che il comunicato è reso disponibile, non depositato, e pertanto non è soggetto alla responsabilità prevista dalla Section 18 e non sarà incorporato per riferimento in altri documenti ai sensi dell'Exchange Act, salvo espressa indicazione. La comunicazione comprende inoltre un Cover Page Interactive Data File (inline XBRL) come Exhibit 104. Il rapporto indica che le azioni ordinarie di Capricor vengono negoziate con il simbolo CAPR sul The Nasdaq Capital Market ed è firmato dalla CEO Linda Marbán, Ph.D.. Gli investitori devono consultare l'Exhibit 99.1 per i dati finanziari dettagliati, poiché il testo dell'8-K qui fornisce solo l'avviso del comunicato.
Capricor Therapeutics remitió un comunicado de prensa que anuncia sus resultados financieros del trimestre cerrado el 30 de junio de 2025; el comunicado se adjunta como Exhibit 99.1. La compañía declara que el comunicado se proporciona, no se presenta, por lo que no está sujeto a la responsabilidad prevista en la Section 18 y no se incorporará por referencia en otras presentaciones en virtud del Exchange Act salvo indicación expresa. La presentación incluye asimismo un Cover Page Interactive Data File (inline XBRL) como Exhibit 104. El informe indica que las acciones ordinarias de Capricor cotizan con el símbolo CAPR en The Nasdaq Capital Market y está firmado por la directora ejecutiva Linda Marbán, Ph.D.. Los inversores deben revisar el Exhibit 99.1 para conocer las cifras financieras detalladas, ya que el texto del 8-K aquí solo notifica el comunicado.
Capricor Therapeutics는 분기 종료일인 2025년 6월 30일자 분기 실적을 발표하는 보도자료를 제공했으며, 해당 보도자료는 Exhibit 99.1로 첨부되어 있습니다. 회사는 이 보도자료가 제출된 것이 아니라 제공된 것(furnished, not filed)이라고 밝히며, 따라서 Section 18에 따른 책임 대상이 아니고 명시적으로 언급되지 않는 한 다른 Exchange Act 제출서류에 참조로 편입되지 않는다고 명시했습니다. 이 제출서류에는 또한 Cover Page Interactive Data File (inline XBRL)이 Exhibit 104로 포함되어 있습니다. 보고서는 Capricor 보통주가 The Nasdaq Capital Market에서 CAPR로 거래되고 있음을 식별하며, CEO Linda Marbán, Ph.D.가 서명했습니다. 투자자는 상세 재무 수치는 Exhibit 99.1을 확인해야 하며, 이 8-K 본문에는 해당 보도자료의 공시 사실만 포함되어 있음을 유의하시기 바랍니다.
Capricor Therapeutics a publié un communiqué de presse annonçant ses résultats financiers pour le trimestre clos le 30 juin 2025 ; le communiqué est joint en tant que Exhibit 99.1. La société précise que le communiqué est fourni, non déposé (furnished, not filed) et n'est donc pas soumis à la responsabilité au titre de la Section 18 et ne sera pas incorporé par renvoi dans d'autres déclarations au titre de l'Exchange Act, sauf indication expresse. Le dépôt comprend également un Cover Page Interactive Data File (inline XBRL) en tant qu'Exhibit 104. Le rapport indique que les actions ordinaires de Capricor sont négociées sous le sigle CAPR sur The Nasdaq Capital Market et est signé par la PDG Linda Marbán, Ph.D.. Les investisseurs doivent consulter l'Exhibit 99.1 pour les chiffres financiers détaillés, car le texte du 8-K se limite ici à annoncer le communiqué.
Capricor Therapeutics hat eine Pressemitteilung veröffentlicht, die die Finanzergebnisse für das zum 30. Juni 2025 endende Quartal bekannt gibt; die Pressemitteilung ist als Exhibit 99.1 beigefügt. Das Unternehmen erklärt, die Mitteilung werde übermittelt, nicht eingereicht (furnished, not filed) und sei daher nicht der Haftung nach Section 18 unterworfen und werde nicht durch Verweis in andere Einreichungen nach dem Exchange Act aufgenommen, sofern nicht ausdrücklich angegeben. Die Einreichung enthält außerdem eine Cover Page Interactive Data File (inline XBRL) als Exhibit 104. Der Bericht weist darauf hin, dass die Capricor-Stammaktien unter dem Kürzel CAPR an der Nasdaq Capital Market gehandelt werden und ist von der Geschäftsführerin Linda Marbán, Ph.D. unterzeichnet. Anleger sollten Exhibit 99.1 zur Einsicht der detaillierten Finanzzahlen heranziehen, da der Text des 8-K hier nur die Veröffentlichung ankündigt.
FAQ
What did Capricor (CAPR) disclose in this 8-K?
Are the financial results included in the 8-K text?
Was the press release filed with the SEC or furnished?
Which securities exchange lists Capricor common stock and what is the ticker?
Who signed the 8-K on behalf of Capricor?
